Bloomberg News

Grindeks Nine-Month Net Income Rises 12.5% on Higher Demand

November 24, 2011

Nov. 24 (Bloomberg) -- AS Grindex, a Latvian drugmaker, said net income rose 12.5 percent in the first nine months of the year to 5.85 million lati ($11.2 million).

Sales rose 4.3 percent to 48.9 million lati in the same period, Grindex said in a regulatory statement today.

--Editor: James M. Gomez

To contact the reporter on this story: Ott Ummelas in Tallinn at oummelas@bloomberg.net

To contact the editor responsible for this story: Balazs Penz at bpenz@bloomberg.net


Ebola Rising
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus